1Meeullough PA,Sandberg KR.Sorting out the evidence on natriuretic peptides[J].Rev Cardio Vase Med,2003,4(Suppl 4):13. 被引量：1
2Jorteni SA,Prabhu SD,Valdes RJ.Strategies for developing biomarkers of heart failure[J].Clin Chem,2004,50(2):265-270. 被引量：1
3Bettencourt P,Frioes F,Azevedo A,et al.Prognostic information plaided by serial measurements of brain natriuretie peptide in heart failure[J].Int J Cardiol,2004,93(1):45-49. 被引量：1
4The Framingham Heart Study.Plasma natriuretic peptide levels and the risk of cardiovascular events and death[J],N Engl J Med,2004,35(1):655-663. 被引量：1
6Latini R,Maggioni AP,Masson S.What does the future hold for BNP in cardiology[J].Heart,2001,86(6):601-611. 被引量：1
7Jernberg T,James S,Lindahl B,et al.NT-proBNP in unstable coronary artery disease-experienees from the FAST,GUSTO Ⅳ and FRISC Ⅱtrials[J].Eur J Heart Fail,2004,6(1):319-325. 被引量：1
8Bazzino O,Fuselli JJ,Botto F,et al.Relative value of N-terminal probrain natriuretic peptide.TIMI risk score,ACC/AHA P regnostic classification and other risk matkers in patients with non-ST-elevation acute coronary syndromes[J].Eur Heart J,2004,25(6):59-866. 被引量：1
9Morrow DA,de Lemos JA,Blazing MA,et al.Progn06tie value of serial B-typenatriuretie peptidetestingduringfollow-up of patients with unstable coronary artery disease[J].JAMA,2005,294(22):28-66. 被引量：1
10GalvaniM,Ferrini D,Ottani F.Natriuretie peptide for risks ratification of patients with acute coronary syndromes[J].Eur J Heart Fail,2004,6(3):227-333. 被引量：1
二级参考文献10
1Talwar S,Downie PF,Squire IB,et al.Plasma N-terminal pro BNP and cardiotrophin-1 are elevated in aortic stenosis[].European Journal of Heart Failure.2001 被引量：1
2Jernberg T,Stridsberg M,Venge P,et al.N-terminal pro-brain natriuretic peptide on admission for early risk stratification of patients with chest pain and no ST-segment elevation[].Journal of the American College of Cardiology.2002 被引量：1
3Luchner A,Hengstenberg C,Lowel H,et al.N-terminal pro-brain natriuretic peptide after myocardial infarction: a marker of cardio-renal function[].Journal of Hypertension.2002 被引量：1
4Bay M,Kirk V,Parner J,et al.NT-proBNP: a new diagnostic screening tool to differentiate between patients with normal and reduced left ventricular systolic function[].Heart.2003 被引量：1
5Pemberton CJ,Johnson ML,Yandle TG,et al.Deconvolution analysis of cardiac natri uretic peptides during acute volume overload[].Journal of Hypertension.2000 被引量：1
6Campbell DJ,Munir V,Hennessy OF,et al.Plasma amino-terminal pro-brain natriuretic peptide levels in subjects presenting to the Emergency Department with suspected acute coronary syndrome: possible role in selecting patients for follow up[].International Medical Journal.2001 被引量：1
7Karl J,Borgya A,Gallusser A,et al.Development of a novel, N-terminal-proBNP ( NT-proBNP) assay with a low detection limit[].Scandinavian Journal of Clinical and Laboratory Investigation.1999 被引量：1
8Pemberton CJ,Yandle TG,Charles CJ,et al.Ovine brain natriuretic peptide in cardiac tissues and plasma: effects of cardiac hypertrophy and heart failure on tissue concentration and molecular forms[].The Journal of Endocrinology.1997 被引量：1
10Nilsson JC,Groenning BA,Nielsen G,et al.Left ventricular remodeling in the first year after acute myocardial infarction and the predictive value of N-terminal pro brain natriuretic peptide[].American Heart Journal.2002 被引量：1
